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Available online 21 July 2016Culex pipiens is an important vector of pathogens of substantial medical and veterinary impor-
tance such as Diroﬁlaria immitis and Diroﬁlaria repens or the West Nile Virus. The control of
these mosquitoes is therefore essential to control the transmission of mosquito-borne agents
to humans and animals. A combination of dinotefuran, permethrin and pyriproxyfen (Vectra®
3D) has already shown its efﬁcacy against Aedes aegypti. The aim of this study was to conﬁrm
the efﬁcacy of this combination in repelling and killing another species of mosquito, Culex
pipiens, after a single topical application to dogs.
Twelve adult Beagle dogs with an equal receptivity to mosquitoes were included in the study
and divided in two groups of six dogs: an untreated control group and a group treated with a
combination containing 54 mg/mL dinotefuran +4.84 mg/mL pyriproxyfen +397 mg/mL per-
methrin (Vectra® 3D). All dogs were challenged with 80 Culex pipiens females for 90 ± 5 min
on Days - 28, 1, 7, 14, 21 and 28. The treatment was applied once topically on Day 0. Count and
engorgement determination of dead and live mosquitoes were performed after each exposure
to treated and untreated dogs.
Compared to control dogs, the spot-on formulation provided a repellent efﬁcacy (anti-feeding
effect) against mosquitoes of 98.9%, 98.8%, 98.6%, 96.7% and 97.9% on Days 1, 7, 14, 21 and 28
respectively. There was a signiﬁcant difference (p ≤ 0.05) between the treated and controlled
groups on every assessment day. The insecticidal efﬁcacy on treated dogs at 90 min was
34.7%, 50.3%, 39.7%, 22.8% and 11.4% on Days 1, 7, 14, 21 and 28 respectively. There was a signiﬁ-
cant difference between the treated and controlled groups for live mosquitoes for all assessment
days (p b 0.05).
A single topical application of a combination of dinotefuran, permethrin and pyriproxyfen showed a
signiﬁcant repellent effect (i.e. N96%) against Culex pipiens which lasted for 28 days. The results
suggest that the Vectra® 3D spot-on solution could be used as an effectivemosquito control strategy
in dogs and is therefore recommended for use in a diroﬁlariosis prevention programme.
© 2016 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
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Culex pipiens mosquitoes play an important role in the transmission of pathogens of signiﬁcant public and veterinary health
importance. They are the primary vectors of the Saint Louis Encephalitis in the USA and the West Nile Virus (WNV, Flaviviridae,
Flavivirus) in Europe and the USA (Farajollahi et al., 2011; Andreadis, 2012; Rizzoli et al., 2015). WNV is normally maintained
through a bird-mosquito cycle but can be spread to a wide range of incidental hosts, such as horses and humans, where it causes
severe neurological disorders (Mackenzie et al., 2004; Ahmetagić et al., 2015). Culex pipiens is one of the main vectors of the zoo-
notic ﬁlarial agents Diroﬁlaria immitis (heartworm) and Diroﬁlaria repens (subcutaneous ﬁlarial worm) (Licitra et al., 2010; Capelli
et al., 2013; Mckay et al., 2013). Diroﬁlaria repens is responsible for subcutaneous diroﬁlariosis in dogs and is often associated with
mild signs or subclinical infections, such as localized itching, mild skin lesions, or subcutaneous nodules in different body areas
(Tarello, 2011). Diroﬁlaria immitis on the contrary causes severe disorders and even death in dogs in many parts of the world
(McCall et al., 2008). In humans, ocular, subcutaneous and pulmonary forms of D. immitis and D. repens have been reported
(McCall et al., 2008; Otranto et al., 2011a, 2011b; Kalogeropoulos et al., 2014).
Therefore it is important to establish an integrated control programme against these mosquitoes to prevent pathogen transmis-
sion to humans and animals in endemic areas. Integrated programmes include the use of mosquito repellents, and one current ap-
proach involves the use of existing molecules in combination (Tiawsirisup et al., 2007; Fankhauser et al., 2015; Franc et al., 2015).
Pyrethroids such as permethrin and deltamethrin have a recognized efﬁcacy against sandﬂies and mosquitoes, and have been used
widely in companion animals (Meyer et al., 2003; Beugnet and Franc, 2012). Dinotefuran is a rapid-acting nitroguanidine
furanicotinyl insecticide, representing a third generation of neonicotinoid. It exerts its action on an acetylcholine receptor present
in the insect nerve synapse by mimicking the action of the neurotransmitter (Wakita et al., 2005). Pyriproxyfen is an analogue of
the insect juvenile hormone. In mosquitoes, pyriproxyfen inhibits the metamorphosis by preventing the emergence of adults from
pupae (Mulligan and Schaefer, 1990; Yapabandara et al., 2001). This juvenile hormone analogue has been widely used in the control
of mosquitoes (i.e. Aedes sp., Culex sp., and Anopheles sp.) especially in malaria endemic areas (Harris et al., 2013; Mbare et al., 2014;
Seccacini et al., 2014). A formulation combining dinotefuran, permethrin and pyriproxyfen (Vectra® 3D, Ceva, France) was launched
in the USA in 2007 and in Europe in 2014. It is indicated for the prevention and treatment of ﬂeas, ticks, ﬂies sandﬂies andmosquitoes
in dogs. This combination has already shown a good efﬁcacy against the mosquito species Aedes aegypti (Franc et al., 2012).
The aim of the study was to evaluate the adulticidal and the repellent effects of Vectra® 3D on Culex pipiens in dogs.
2. Materials and methods
The study was conducted at the National Veterinary School of Toulouse (Ecole Nationale Vétérinaire de Toulouse, ENVT), France,
according to the Good Clinical Practices (GCP study). The protocol was approved by the local Ethics Committee and dogs were han-
dled in accordance with the animal welfare and the local Institutional Animal Care and Use Committee requirements (ethical clear-
ance MP/14280312). All personnel involved with the collection of efﬁcacy data were blinded to the treatment.
2.1. Dogs
Twelve Beagle dogs (six females and six males aged between 2 and 10 years and weighing between 9.01 and 12.95 kg) were
included in the study and acclimatized to the trial environment for 38 days prior to treatment. They had not been exposed to
short-acting ectoparasiticides for 3 months prior to the inclusion and had never been treated with any long-acting
ectoparasiticides. They were housed in individual boxes and had a four-hour daily access to a 4 × 4 m concrete run where
they could run and play with toys. Control and treated dogs were placed in two different exercise areas to avoid cross contam-
ination. Dogs were observed daily for their general health conditions and remained in good health throughout the study.
On Day - 28 each dog was challenged with 80 unfed adult Culex pipiens females to assess their receptivity to mosquitoes. The
number of engorged female mosquitoes was used for allocation to groups. Dogs were ranked in descending order of their individ-
ual mosquito's engorgement status and six blocks of two animals each were formed. Within blocks, dogs were randomly allocated
to the treatment or control group.
2.2. Mosquito maintenance and supply
The Culex pipiens female mosquitoes used in this trial were reared at the ENVT laboratory and were 15-day old when used for
infestation. The colony was originated from the Interdepartmental agreement for Mosquito Control on the Mediterranean coast
(Entente Interdépartementale de Démoustication, EID), Montpellier, France, and was maintained at ENVT under laboratory condi-
tions since 2001.
2.3. Treatment
The six dogs from the control group were not treated, and the other six received on Day 0 a topical combination of dinotefuran,
pyriproxyfen and permethrin. Theywere treatedwith the commercial dose of the product based on their bodyweight (1.6mL pipette
for dogs weighing between 4.1 and 10.0 kg and 3.6 mL pipette for dogs weighing between 10.1 and 25 kg). Dogs were administered
0.23± 0.08 mL/kg BWof the solution corresponding to 12.67 mg/kg± 4.08 of dinotefuran, 92.33 mg/kg± 29.77 of permethrin and
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in two points for the 1.6 mL pipette (between shoulder blades and on the lumbar area) and in three points for the 3.6 mL pipette
(between shoulder blades, on the dorsal midline and on the lumbar area). The formulation was provided by CEVA Animal Health.
All dogs were observed at 2 and 4 h after treatment for any adverse reaction to the product.
2.4. Experimental procedure
The 12 dogs were infested with 80 (±2) C. pipiens females on Days - 28, 1, 7, 14, 21 and 28. Before exposure, dogs were se-
dated by intramuscular injection of a mixture of medetomidine (Dexdomitor®, Pﬁzer Santé animale, Paris, France) and ketamine
(Imalgène 1000®, Laboratoire Mérial, Lyon, France) at a dose rate of 5 μg/kg and 5 mg/kg respectively. Once sedated they re-
ceived an intramuscular injection of diazepam (Valium®, Roche injectable, Neuilly s/ Seine, France) at a dose rate of 0.5 mg/kg,
before they were placed in the individual nets containing mosquitoes. The dosage of the anaesthetic was calculated so as to
immobilize dogs for 90 min and additional amount of the products were administered when needed.
Two days before exposure, mosquitoes were aspirated from their breeding cage with a vacuum pump and then placed in each
challenge net. They were provided cottons soaked with water and had honey at their disposal. They were fasted 24 h before
exposure to dogs by removing honey from each infestation net. The cottons soaked with water were removed at the introduction
of the dogs. During exposure to mosquitoes, treated and controlled dogs were placed in two separated infestation rooms where
temperature and relative humidity were maintained at 25 °C ± 3 °C and 60% ± 5% respectively. The light was turned off during
the hour of exposure.
After 90 ± 5 min of exposure, the dogs were carefully taken out of the net and examined for any dead mosquito on their body,
and then were returned to their individual box. Live mosquitoes were aspirated from each net and were classiﬁed as live
engorged or live non-engorged. The engorgement status was determined by observation of the abdomen distension and the pres-
ence of blood in it with the naked eye. All dead mosquitoes were collected and classiﬁed as dead engorged or dead non-engorged.
Remaining live mosquitoes recovered from each dog were placed in separate nets and kept in the experimental room. They were
checked for mortality 24 h after. Then, all remaining mosquitoes were discarded.
After each mosquito challenge, cages and nets were thoroughly cleaned.
2.5. Data analysis
2.5.1. Antifeeding effect or repellency
For each time point after exposure, the antifeeding effect was calculated as described below:Anti−feeding effect ¼ 100 Ce‐Te
CeCe stands for the arithmetic mean of engorged females mosquitoes (live engorged + dead engorged) for the controlled group
and Te is the arithmetic mean of engorged female mosquitoes for the treated group.
2.5.2. Mortality effect (or insecticidal effect)
For each time point after exposure, the mortality effect was evaluated for each group as described below:Mortality effect ¼ 100 Cl‐Tl
ClCl stands for the arithmetic mean of live females mosquitoes (live engorged + live unengorged) for the controlled group and
Tl was the arithmetic mean of live female mosquitoes for the treated group.
The mortality effect was calculated at 90 min and 24 h post-exposure.
2.6. Statistical analysis
The two groupswere compared for the number of engorged females and the number of dead females at each challenge point. They
were subjected to general linearmodel (GLM) procedures (split model) with the software Systat 12.0 (Systat, USA) to determine the
effect of 3 factors: group (treated or control group), day of examination and dog (as random factor) and the interaction Group ∗ Day
on the numbers of mosquitoes engorged or dead at 1.5 h and 24 h after their exposition to dogs. Means were separated with the
Tukey's honest signiﬁcance test (Systat 12.0). Insect capture data were transformedwith square root prior to analysis and back trans-
formed values are given in text and tables. Differences were considered signiﬁcant at p b 0.05.
3. Results
The treatment was well tolerated and no adverse events were reported. According to the GLM results, the Group and Day
effects were signiﬁcant as well as associated interaction Group ∗ Day (p b 0.05) but not the Dog effect (p N 0.05).
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The 12 dogs included in the study demonstrated a good pre-treatment parasite holding ability or receptivity: above 50% of
engorged females per dog (Fig. 1). On Day-28, the mean number of engorged female mosquitoes was 66.3 and 66 out of 80
for the control and treatment group respectively. All control dogs maintained an adequate number of engorged females (i.e.
mean number above 55) throughout the study (Fig. 1).
The treatment had an anti-feeding effect above 98.6% for the ﬁrst three expositions post-treatment (ﬁrst two weeks) and
remained above 96.7% until the end of the trial (Table 1). At each challenge point post-treatment the difference in the engorge-
ment status of C. pipiens females between treated and controlled group was signiﬁcant (p b 0.05).
3.2. Mortality effect (or insecticidal effect) on mosquitoes
The mortality effects of the treatment calculated at 1.5 h and 24 h post-exposure to treated dogs are reported in Table 1. The
mortality effect observed at 1.5 h ranged between 34.7% and 50.3% for the ﬁrst two weeks after treatment and then dropped to
values ranging between 11.4% and 22.8% for the last two expositions. The mortality effect of the formulation did not increase
signiﬁcantly within the 24 h post-exposure (Table 1). At each challenge point, there was a signiﬁcant difference (p b 0.05) in
the number of dead mosquitoes found at 1.5 h and 24 h of exposure between the treated and controlled group.
4. Discussion
The results of this study showed that a single topical application of a combination of dinotefuran 4.95% (w/w), pyriproxyfen
0.44% (w/w) and permethrin 36.08% (w/w) (Vectra® 3D, Ceva, Libourne, France) provided an excellent feeding inhibition of
Culex pipiens mosquitoes which lasted for four weeks. The combination provided a strong immediate effect with a 98.9% repellen-
cy reached 24 h after treatment. This efﬁcacy remained above 96.7% for 28 days.
Recent studies reported the efﬁcacy of other combinations containing permethrin combined with ﬁpronil (Efﬁtix®, Frontline
Tri-Act®/Frontect®) on the same target, Culex pipiens (Fankhauser et al., 2015; Franc et al., 2015). The feeding inhibition provided
by Vectra® 3D was similar or even better to the one obtained with these both new spot-on formulations containing approximate-
ly the same dose of permethrin. The repellency of Efﬁtix® against C. pipiens was 100% (Day 1), 99.5% (Day 7), 97.7% (Day 14),
98.3% (Day 21) and 96.7% (Day 28) (Franc et al., 2015) while the efﬁcacy of Frontline Tri-Act®/Frontect® was a bit lower with
99.4% (Day 1), 98.9% (Day 7), 94.7% (Day 14), 91.7% (Day 21) and 90.4% (Day 28) (Fankhauser et al., 2015).
The efﬁcacy of Vectra® 3D was investigated in a previous study on another mosquito strain, Aedes aegypti, under the same
laboratory conditions (Franc et al., 2012). The repellency reached 91.5% on Day 1, 94% on Days, 7, 14 and 21 and 87% on Day
28, which was close to the repellency obtained with C. pipiens. However differences in insecticidal efﬁcacies were observed
between these two mosquito species. Vectra® 3D presented an insecticidal efﬁcacy against C. pipiens remaining between 50.3%
(Day 7) and 11.4% (Day 28). On the contrary, the insecticidal efﬁcacy against A. aegypti was signiﬁcantly higher (i.e. N93%) despite
a shorter exposure time to treated dogs (60 versus 90 min) (Franc et al., 2012). Interestingly, similar discrepancies were obtained
by Fankhauser et al. (2015) with permethrin combined with ﬁpronil (Frontline Tri-Act®/Frontect®) against C. pipiens and
A. aegypti. The authors obtained an insecticidal efﬁcacy against C. pipiens of 77.9%, 92.1%, 34.7%, 38.5% and 26.9% on Days 2, 8,
15, 22 and 29 while the insecticidal efﬁcacy obtained against A. aegypti was 99.8%, 93.8%, 69.5%, 77% and 20.9% on Days 1, 7,
14, 21 and 28 respectively. They suggested that the repellent effect of permethrin combined with ﬁpronil was stronger on
C. pipiens than on A. aegypti therefore preventing them from landing on the treated dogs, thus limiting the contact with theFig. 1. Mean number of engorged Culex pipiens females after 90 min exposure to control and treated dogs. Dogs from treated group received on Day 0 a spot-on
combination of dinotefuran, permethrin and pyriproxyfen (Vectra® 3D), dogs from controlled group remained untreated. All dogs were weekly challenged with 80
Culex pipiens females. At each challenge point after treatment, the differences between groups were statistically signiﬁcant (p b 0.05). *** represents statistical dif-
ferences at p b 0.0001.
Table 1
Mortality and anti-feeding effect of a dinotefuran, permethrin and pyriproxyfen spot-on combination (Vectra® 3D) against Culex pipiens females on dogs.
Day 1 Day 7 Day 14 Day 21 Day 28
Anti-feeding effect (%)
(95%CI)
1.5 h 98.9 (93–100) 98.8 (92.6–100) 98.6 (92–100) 96.7 (86.6–100) 97.9 (89.8–100)
Mortality effect (%)
(95%CI)
1.5 h 34.7 (7.8–61.6) 50.3 (22–78.6) 39.7 (12–67.4) 22.8 (0–46.5) 11.4 (0.-29.4)
24 h 40.2 (12.5–67.9) 51.0 (22.7–79.3) 41.2 (13.4–69) 22.3 (0–45.9) 34.8 (7.8–61.8)
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mosquito species. Lupi et al. (2013) investigated the literature review of repellency studies conducted on different products
(DEET, Icaridin, Insect Repellent and plant-derived products (Citriodora or paramenthane-3,8-diol)) against Anopheles sp., Culex
sp. and Aedes sp. regarding human skin. All the tested molecules provided a better repellency (anti-feeding effect) on Culex sp.
than on Anopheles sp. or Aedes sp. The authors reported also that Aedes sp. demonstrated a more aggressive biting behaviour
than Culex sp. This aggressive behaviour has also been observed in our experimental conditions in which dogs were infested
with mosquitoes. Once in contact with dogs, A. albopictus or A. aegypti land and bite more promptly than C. pipiens that take
longer before tempting to feed (authors' personal observations). This behaviour could explain that the contact duration of
Aedes sp. mosquitoes with the treated skin is increased, therefore improving the insecticidal efﬁcacy (or mortality effect) of the
molecule. A further reason could be related to the different feeding preferences of C. pipiens in comparison to Aedes sp:
C. pipiens feeds preferentially on avian hosts while Aedes, especially A. albopictus, tends to feed predominantely on mammals
including humans and pets (Gomes et al., 2013; Faraji et al., 2014; Valerio et al., 2010). However, further behavioural studies
would be necessary to investigate this difference in host attractancy under laboratory conditions. These observations would
bring signiﬁcant inputs to the design of repellency studies using mosquitoes, as the exposure duration to the hosts must be
long enough to allow a good feeding rate on control animals.
Vectra® 3D is currently the only ectoparasiticidal combination for dogs containing dinotefuran. This molecule has a low afﬁnity
for binding sites of other neonicotinoid insecticides and has no cross-resistance with common parasiticides, such as permethrin
(Wakita et al., 2005). Therefore, dinotefuran has been proposed as a potential candidate for vector control in areas with resistance
of mosquitoes to other insecticides (Corbel et al., 2004).
5. Conclusion
A combination of dinotefuran, pyriproxyfen and permethrin provides a good protection (i.e. a repellency above 96.7%) against
Culex pipiens in dogs for one month following a single topical application. Therefore this treatment could be included in an
integrated prevention program against heartworm disease for dogs living in or travelling to diroﬁlariosis endemic areas. However,
it should not be seen as a substitute for heartworm prevention treatments.
Competing interests
The work reported here was partially funded by a grant from Ceva Santé Animale (CEVA-ST-CLS-C661-1203), Libourne, France.
Two authors (MV and AD) are currently employees of Ceva Santé Animale, and assisted with the study design and the review of
the manuscript. However, there were no conﬂicts of interests that may have biased the work reported in this paper.
Acknowledgments
The authors are grateful to Sonia Gounaud and Martine Roques for their help with the mosquito colony maintenance and the
handling of dogs.
References
Ahmetagić, S., Petković, J., Hukić, M., Smriko-Nuhanović, A., Piljić, D., 2015. Human West Nile virus infection in Bosnia and Herzegovina. Med. Glas. 12, 47–51.
Andreadis, T.G., 2012. The contribution of Culex pipiens complex mosquitoes to transmission and persistence ofWest Nile virus in North America. J. Am. Mosq. Control
Assoc. 28, 137–151.
Beugnet, F., Franc, M., 2012. Insecticide and acaricide molecules and/or combinations to prevent pet infestation by ectoparasites. Trends Parasitol. 28, 267–279.
Capelli, G., Frangipane di Regalbono, A., Simonato, G., Cassini, R., Cazzin, S., Cancrini, G., Otranto, D., Pietrobelli, M., 2013. Risk of canine and human exposure to
Dirofilaria immitis infected mosquitoes in endemic areas of Italy. Parasit Vectors 6, 60.
Corbel, V., Duchon, S., Zaim, M., Hougard, J.M., 2004. Dinotefuran: a potential neonicotinoid insecticide against resistant mosquitoes. J. Med. Entomol. 41, 712–717.
Fankhauser, B., Dumont, P., Hunter, J.S., McCall, J.W., Kaufmann, C., Mathis, A., Young, D.R., Carroll, S.P., McCall, S., Chester, S., Soll, M.D., 2015. Repellent and insecticidal
efficacy of a new combination of fipronil and permethrin against threemosquito species (Aedes albopictus, Aedes aegypti and Culex pipiens) on dogs. Parasit Vectors
8, 64.
Faraji, A., Egizi, A., Fonseca, D.M., Unlu, I., Crepeau, T., Healy, S.P., Gaugler, R., 2014. Comparative host feeding patterns of the Asian tiger mosquito, Aedes albopictus, in
urban and suburban Northeastern USA and implications for disease transmission. PLoS Negl. Trop. Dis. 8, e3037.
Farajollahi, A., Fonseca, D.M., Kramer, L.D., Marm Kilpatrick, A., 2011. “Bird biting” mosquitoes and human disease: a review of the role of Culex pipiens complex
mosquitoes in epidemiology. Infect. Genet. Evol. 11, 1577–1585.
238 E. Bouhsira et al. / Parasite Epidemiology and Control 1 (2016) 233–238Franc,M., Genchi, C., Bouhsira, E., Warin, S., Kaltsatos, V., Baduel, L., Genchi, M., 2012. Efficacy of dinotefuran, permethrin and pyriproxyfen combination spot-on against
Aedes aegyptimosquitoes on dogs. Vet. Parasitol. 189, 333–337.
Franc, M., Lienard, E., Jacquiet, P., Bonneau, S., Bouhsira, E., 2015. Efficacy of fipronil combined with permethrin commercial spot on (Effitix®) preventing Culex pipiens
from feeding on dogs. Parasitol. Res. 114, 2093–2097.
Gomes, B., Sousa, C.A., Vicente, J.L., Pinho, L., Calderón, I., Arez, E., Almeida, A.P., Donnelly, M.J., Pinto, J., 2013. Feeding patterns of molestus and pipiens forms of Culex
pipiens (Diptera: Culicidae) in a region of high hybridization. Parasit Vectors 6, 93.
Harris, C., Lwetoijera, D.W., Dongus, S., Matowo, N.S., Lorenz, L.M., Devine, G.J., Majambere, S., 2013. Sterilising effects of pyriproxyfen on Anopheles arabiensis and its
potential use in malaria control. Parasit Vectors 6, 144.
Kalogeropoulos, C.D., Stefaniotou, M.I., Gorgoli, K.E., Papadopoulou, C.V., Pappa, C.N., Paschidis, C.A., 2014. Ocular dirofilariasis: a case series of 8 patients. Middle East
Afr. J. Ophthalmol. 21, 312–316.
Licitra, B., Chambers, E.W., Kelly, R., Burkot, T.R., 2010. Detection of Dirofilaria immitis (Nematoda: Filarioidea) by polymerase chain reaction in Aedes albopictus,
Anopheles punctipennis, and Anopheles crucians (Diptera: Culicidae) from Georgia, USA. J. Med. Entomol. 474, 634–638.
Lupi, E., Hatz, C., Schlagenhauf, P., 2013. The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. - a literature review. Travel Med. Infect. Dis. 11,
374–411.
Mackenzie, J.S., Gubler, D.J., Petersen, L.R., 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10
(12), 98–109.
Mbare, O., Lindsay, S.W., Fillinger, U., 2014. Pyriproxyfen for mosquito control: female sterilization or horizontal transfer to oviposition substrates by Anopheles gambiae
sensu stricto and Culex quinquefasciatus. Parasit Vectors 7, 280.
McCall, J.W., Genchi, C., Kramer, L.H., Guerrero, J., Venco, L., 2008. Heartworm disease in animals and humans. Adv. Parasitol. 66, 193–285.
Mckay, T., Bianco, T., Rhodes, L., Barnett, S., 2013. Prevalence of Dirofilaria immitis (Nematoda: Filarioidea) in mosquitoes from northeast Arkansas, the United States.
J. Med. Entomol. 50, 871–878.
Meyer, J.A., Disch, D., Cruthers, L.R., Slone, R.L., Endris, R.G., 2003. Repellency and efficacy of a 65% permethrin spot-on formulation for dogs against Aedes aegypti
(Diptera: Culicidae) mosquitoes. Vet. Ther. 4, 135–144.
Mulligan, F.S., Schaefer, C.H., 1990. Efficacy of a juvenile hormone mimic, pyriproxyfen (S-31183) for mosquito control in dairy waste water lagoons. J. Am. Mosq. Con-
trol Assoc. 6, 89–92.
Otranto, D., Brianti, E., Gaglio, G., Dantas-Torres, F., Azzaro, S., Giannetto, S., 2011a. Human ocular infection with Dirofilaria repens (Railliet and Henry, 1911) in an area
endemic for canine dirofilariasis. Am.J.Trop. Med. Hyg. 46, 1002–1004.
Otranto, D., Diniz, D.G., Dantas-Torres, F., Casiraghi, M., de Almeida, I.N., de Almeida, L.N., dos Santos, J.N., Furtado, A.P., de Almeida Sobrinho, E.F., Bain, O., 2011b.
Human intraocular filariasis caused by Dirofilaria sp. nematode, Brazil. Emerg. Infect. Dis. 17, 863–866.
Rizzoli, A., Bolzoni, L., Chadwick, E.A., Capelli, G., Montarsi, F., Grisenti, M., De la Puente, J.M., Muñoz, J., Figuerola, J., Soriguer, R., Anfora, G., Di Luca, M., Rosà, R., 2015.
Understanding West Nile virus ecology in Europe: Culex pipiens host feeding preference in a hotspot of virus emergence. Parasit Vectors 8, 213.
Seccacini, E., Juan, L., Zerba, E., Licastro, S., 2014. Aedes aegypti (Diptera: Culicidae): evaluation of natural long-lasting materials containing pyriproxyfen to improve
control strategies. Parasitol. Res. 113, 3355–3360.
Tarello, W., 2011. Clinical aspects of dermatitis associated with Dirofilaria repens in pets: a review of 100 canine and 31 feline cases (1990–2010) and a report of a new
clinic case imported from Italy to Dubai. J. Parasitol. Res. 2011, 578385.
Tiawsirisup, S., Nithiuthai, S., Kaewthamasorn, M., 2007. Repellent and adulticide efficacy of a combination containing 10% imidacloprid and 50% permethrin against
Aedes aegyptimosquitoes on dogs. Parasitol. Res. 1013, 527–531.
Valerio, L., Marini, F., Bongiorno, G., Facchinelli, L., Pombi, M., Caputo, B., Maroli, M., Della Torre, A., 2010. Host-feeding patterns of Aedes albopictus (Diptera: Culicidae)
in urban and rural contexts within Rome province, Italy. Vector Borne Zoonotic Dis. 10, 291–294.
Wakita, T., Yasui, N., Yamada, E., Kishi, D., 2005. Development of a novel insecticide, dinotefuran. J. Pestic. Sci. 30, 122–123.
Yapabandara, A.M., Curtis, C.F., Wickramasinghe, M.B., Fernando,W.P., 2001. Control of malaria vectors with the insect growth regulator pyriproxyfen in a gem-mining
area in Sri Lanka. Acta Trop. 80, 265–276.
